# 63% of Americans expect injectable weight-loss drugs to keep gaining users

Canonical page: https://data.verasight.io/health/63-of-americans-expect-injectable-weight-loss-drugs-to-keep-gaining-users/

> Indexed question in Health.

## Reading

In a Verasight survey conducted Aug. 1-6, 2025, nearly two-thirds of Americans (63%) expect the use of injectable weight-loss drugs like Ozempic to keep climbing beyond current levels.

About one-in-five (18%) do not, and a similar share (19%) are unsure.

## Topline

In your opinion, will the use of injectable weight loss drugs (like Ozempic) continue to grow, beyond it's current level of use?

63% of Americans expect injectable weight-loss drugs to keep gaining users.

- Yes: 63.1%
- Don't know: 19.0%
- No: 17.8%

## Methodology

- Mode: Verasight panel recruited via random address-based sampling, random person-to-person text messaging, and dynamic online targeting
- Population: United States adults
- Field dates: 2025-08-01 → 2025-08-06
- Base (unweighted): 1,000
- Margin of error: +/- 3.2%
- Module: B
- Sponsor: Verasight
- Weight variable: weight
- Weighting targets: age, race/ethnicity, sex, income, education, region, metropolitan status

## Source

- Canonical question URL: [https://verasight-quirks-2025.tiiny.co#injectable-weight-loss-drugs](https://verasight-quirks-2025.tiiny.co#injectable-weight-loss-drugs)

## Citation

Verasight Quirks Omnibus Survey, fielded August 1-6, 2025, N=1,000 United States adults, +/- 3.2%.

Canonical question URL: [https://verasight-quirks-2025.tiiny.co#injectable-weight-loss-drugs](https://verasight-quirks-2025.tiiny.co#injectable-weight-loss-drugs)